Healthcare press releases — Press Release Database

Healthcare

Recent Release, "A Healthy Transformation," from Christian Faith Publishing Author Deodge Hill, Explores How Believers Can Honor God Through Their Bodies and Wellness

Deodge Hill has completed a new book, "A Healthy Transformation: Fit for His Purpose," a faith-centered guide designed to help readers achieve physical, mental, and spiritual wholeness. By seamlessly blending practical health principles with biblical encouragement, this work equips believers to break free from unhealthy patterns, establish sustainable habits, and discover how their wellness journey connects to [PR.com]

Aug 31 · 10:00PR.com

Healthcare

Recent Release, "Inspired to Influence," from Christian Faith Publishing Author Angel Morgan, Chronicles a Transformative Spiritual Journey Through Challenging Seasons

Angel Morgan has completed a new book, titled, "Inspired to Influence" that traces her personal expedition through invisibility, loss, and ultimately, profound restoration. When facing medical emergencies, devastating diagnoses, and the untimely death of beloved family members, Morgan found herself emotionally overwhelmed and mentally struggling to process her circumstances. Isolated despite having loving family [PR.com]

Aug 31 · 10:00PR.com

Healthcare

Medical Device Coatings Market Benefits From Antimicrobial Solutions

The global Medical Device Coatings Market was valued at USD 16.3 billion in 2025 and is projected to reach USD 30.0 billion by 2033, expanding at a 7.9% CAGR from 2026 [read full press release...]

Aug 31 · 09:53Express Press Release

Finance · Healthcare

Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026

HOUSTON, Aug. 31, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric,...

Aug 31 · 09:30PR Newswire

Finance · Healthcare

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

REYKJAVIK, Iceland, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT80, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) prefilled syringe and autoinjector for subcutaneous administration.

Aug 31 · 08:30GlobeNewswire

Finance · Healthcare

Matvæla- og lyfjastofnun Bandaríkjanna (FDA) tekur til afgreiðslu umsókn Alvotech um markaðsleyfi fyrir fyrirhugaða hliðstæðu við Entyvio í sprautu eða lyfjapenna

REYKJAVÍK (31. ágúst 2026) – Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hefði tekið til afgreiðslu umsókn um markaðsleyfi í Bandaríkjunum fyrir AVT80, fyrirhugaða hliðstæðu með útskiptileika við Entyivo (vedolizumab) í áfylltri sprautu eða lyfjapenna.

Aug 31 · 08:30GlobeNewswire

Healthcare

National #VoteLikeHealth Campaign to Put Healthcare at Center of Midterm Elections

Community Catalyst, the nation's leading health advocacy organization, this morning launched its Vote Like Your Health Depends On It campaign (#VoteLikeHealth) ahead of the midterm elections in November. BOSTON, Aug. 31, 2026 /PRNewswire-PRWeb/ -- Community Catalyst, the nation's leading...

Aug 31 · 08:00PRWeb

Healthcare

Why the Pharma HUB And Patient Access Support Service Market Is at an Inflection Point

Patient support hubs have quietly become one of the most strategically important — and most contested — functions in pharmaceutical commercialization. For years, the model [read full press release...]

Aug 31 · 06:58Express Press Release

Finance · Healthcare

BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea

Agreement Resolves all Pending Patent-Related Proceedings Between BioMarin and Ascendis SAN RAFAEL, Calif., Aug. 30, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it has entered into binding terms with Ascendis Pharma A/S, resolving the patent and...

Aug 31 · 06:00mlpr-prnewswire-wire

Healthcare

HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026: A New Era in Wrist-Based Blood Pressure Management

MUNICH, Aug. 31, 2026 /PRNewswire/ -- The European Society of Cardiology Congress (ESC Congress 2026), one of the world's most influential academic gatherings in cardiovascular medicine, officially kicked off today in Munich, Germany. Huawei showcased its latest innovations in health and...

Aug 31 · 04:23PR Newswire

AI · Healthcare

SpeedyIndex Brings AI Agents to Link Building: Donor Domains to Be Scored by Long-Term Indexing Health

An AI Consultant in the SpeedyIndex dashboard handled 57% of support requests in its first week. Next up, in Q4 2026: AI agents that rate donor domains by how Google has indexed them over months, quarters and years VANTAA, Finland and HELSINKI, Aug. 30, 2026 /PRNewswire-PRWeb/ --...

Aug 31 · 03:57PRWeb

Finance · Healthcare

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China

Findings build on the established success of the global SAFFRON and China SACHI trials, extending the clinical value of the all-oral combination into the first-line setting Findings build on the established success of the global SAFFRON and China SACHI trials, extending the clinical value of the all-oral combination into the first-line setting

Aug 31 · 00:00GlobeNewswire